These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11600817)

  • 1. [Immunobiology of the non-small-cell lung carcinoma: new aspects].
    Fischer JR; Neuner A; Muley T; Lahm H; Drings P
    Onkologie; 2001 Sep; 24 Suppl 5():72-4. PubMed ID: 11600817
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of CD4+ pleural cavity lymphocytes in non-small cell lung cancer].
    Takahashi K
    Nihon Rinsho; 2002 May; 60 Suppl 5():272-5. PubMed ID: 12101671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of PCNA expression in non-small cell lung cancer].
    Dworakowska D
    Pneumonol Alergol Pol; 2005; 73(3):292-6. PubMed ID: 16989169
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoembryonic antigen level in serum and pleural lavage fluid in non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T
    Thorac Cardiovasc Surg; 2010 Sep; 58(6):350-3. PubMed ID: 20824588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma.
    da Costa Souza P; Parra ER; Atanazio MJ; da Silva OB; Noleto GS; Ab'Saber AM; de Morais Fernezlian S; Takagaki T; Capelozzi VL
    Histopathology; 2012 Oct; 61(4):587-96. PubMed ID: 22716510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
    Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer.
    Monstad SE; Drivsholm L; Storstein A; Aarseth JH; Haugen M; Lang B; Vincent A; Vedeler CA
    J Clin Oncol; 2004 Mar; 22(5):795-800. PubMed ID: 14990634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prognostic factors on endpoints for clinical studies.
    Sørensen JB
    Lung Cancer; 1994 Nov; 11 Suppl 3():S45-54. PubMed ID: 7704512
    [No Abstract]   [Full Text] [Related]  

  • 10. P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
    Bergqvist M; Brattström D; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Wagenius G; Brodin O
    Anticancer Res; 1998; 18(3B):1999-2002. PubMed ID: 9677456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted programmed cell death in lung cancer treatment.
    Zimmerman MP; Mehr SR
    Am J Manag Care; 2014 Mar; 20(5 Spec No.):E3. PubMed ID: 25618630
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer.
    Lohr M; Edlund K; Botling J; Hammad S; Hellwig B; Othman A; Berglund A; Lambe M; Holmberg L; Ekman S; Bergqvist M; Pontén F; Cadenas C; Marchan R; Hengstler JG; Rahnenführer J; Micke P
    Cancer Lett; 2013 Jun; 333(2):222-8. PubMed ID: 23370224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
    Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
    Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dendritic cell vaccines pulsed with Wilms' tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers.
    Takahashi H; Okamoto M; Shimodaira S; Tsujitani S; Nagaya M; Ishidao T; Kishimoto J; Yonemitsu Y;
    Eur J Cancer; 2013 Mar; 49(4):852-9. PubMed ID: 23245331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
    Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
    Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intervention effect of Feiji Recipe on immune escape of lung cancer].
    Huang YS; Shi ZM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun; 27(6):501-4. PubMed ID: 17633360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis.
    Orditura M; De Vita F; Catalano G; Infusino S; Lieto E; Martinelli E; Morgillo F; Castellano P; Pignatelli C; Galizia G
    J Interferon Cytokine Res; 2002 Nov; 22(11):1129-35. PubMed ID: 12513912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
    Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
    Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
    Hsiao KC; Shih NY; Chu PY; Hung YM; Liao JY; Chou SW; Yang YY; Chang GC; Liu KJ
    Oncotarget; 2015 Oct; 6(33):35073-86. PubMed ID: 26551021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.